COMMUNIQUÉS West-GlobeNewswire

Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07/03/2024
LOWELL, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate [...]
PickleJar Confirms Completion of Its Two-Year Audit and Applies for FINRA Name Change
06/03/2024
Company furthers its corporate mission, aiming to expand brand reach and shareholder communications HOUSTON, TX, March 06, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – PickleJar Entertainment Group (OTC:NREG f/k/a [...]
Viemed Healthcare Announces Record 2023 Financial Results
06/03/2024
LAFAYETTE, La., March 06, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, [...]
BioVie Inc. Announces Closing of Public Offering
06/03/2024
CARSON CITY, Nev., March 06, 2024 (GLOBE NEWSWIRE) -- BioVie Inc. (Nasdaq: BIVI), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions [...]
SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management Technology
06/03/2024
TEL AVIV, Israel, March 06, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders [...]
Lytus Technologies Enters $326 Billion Data Center Market with Launch of Cutting-Edge Lytus Cloud Infrastructure Services
06/03/2024
Dubai, UAE, March 06, 2024 (GLOBE NEWSWIRE) -- Lytus Technologies Holdings PTV. Ltd. (the “Company”) (Nasdaq:LYT), a leading global technology-driven services company, today announced the launch of Lytus Cloud, a [...]
MedBright AI Announces Investor Relations Agreement with Anthem Strategies Ltd.
06/03/2024
VANCOUVER, British Columbia, March 06, 2024 (GLOBE NEWSWIRE) -- MedBright AI Investments Inc. (the “Company” or “MedBright AI”) (CSE:MBAI, OTCQB:MBAIF, FSE:1V7) announces that it has entered into an investor relations [...]
Avid Bioservices Announces Proposed Private Placement of Convertible Notes
06/03/2024
TUSTIN, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO), announced today that it intends to offer, [...]
Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024
06/03/2024
TUSTIN, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing [...]
Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results
06/03/2024
Fourth Quarter 2023 Total Revenues of $277 million, which aligned our Full Year to the mid-point of guidance Full Year 2023 Total Revenues of $1.05 billion, which was the mid-point of guidance Fourth Quarter 2023 Net [...]
Supernus to Participate in Two Upcoming Investor Conferences
06/03/2024
ROCKVILLE, Md., March 06, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous [...]
Pathway Health Launches Learning Institute and Education Advisory Board
06/03/2024
The Pathway Learning Institute will develop evidence-based education and board certification programs to support the development of senior care clinical and operational leaders. LAKE ELMO, Minn., March 06, 2024 (GLOBE [...]
ORIC Pharmaceuticals to Present at the Leerink Partners Global Biopharma Conference
06/03/2024
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, March 06, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of [...]
Disc Medicine to Participate in the Leerink Partners Global Biopharma Conference 2024
06/03/2024
WATERTOWN, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for [...]
BioSyent Schedules Fourth Quarter and Full Year 2023 Earnings Release for March 13, 2024
06/03/2024
MISSISSAUGA, Ontario, March 06, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months and full year ended December 31, 2023 on [...]
Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
06/03/2024
- Company is leveraging proprietary cell-targeted lipid nanoparticle delivery to develop wholly-owned in vivo program for sickle cell disease and beta-thalassemia - Development of breakthrough immune-quiet DNA for [...]
Nanobiotix to Present at Upcoming Investor Conferences in March
06/03/2024
PARIS and CAMBRIDGE, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘ Company ’’), a late-clinical stage biotechnology company pioneering physics-based approaches to expand [...]
Nanobiotix participera à des conférences investisseurs en mars
06/03/2024
PARIS et CAMBRIDGE, Mass., 06 mars 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO –– NASDAQ : NBTX – la « Société » ), société française de biotechnologie en phase de développement clinique avancé, pionnière des [...]
TransCode Therapeutics To Present At 2024 RNA Leaders Europe Congress
06/03/2024
Highlights TTX-MC138’s Path from Target Discovery to the Clinic BOSTON, March 06, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating [...]

Pages